- Report
- September 2026
- 199 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 188 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 278 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- May 2026
- 180 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- November 2025
- 200 Pages
Global
From €7229EUR$7,950USD£6,215GBP
- Report
- May 2026
- 150 Pages
Global
From €2454EUR$2,699USD£2,110GBP
- Report
- March 2023
- 147 Pages
Global
From €4500EUR$4,949USD£3,869GBP
- Report
- May 2024
- 140 Pages
Global
From €2727EUR$2,999USD£2,345GBP
€3636EUR$3,999USD£3,126GBP
Fludrocortisone is a synthetic glucocorticoid used to treat endocrine and metabolic disorders. It is used to treat Addison's disease, a condition in which the body does not produce enough of its own cortisol, and to treat salt-losing adrenogenital syndrome, a condition in which the body does not retain enough salt. Fludrocortisone is also used to treat certain types of low blood pressure, such as postural hypotension. It works by increasing the amount of salt and water in the body, which helps to raise blood pressure.
Fludrocortisone is available in tablet form and is usually taken once or twice daily. It is important to follow the doctor's instructions when taking this medication. Common side effects include nausea, vomiting, headache, and dizziness.
The fludrocortisone market is a part of the larger endocrine and metabolic disorders drugs market. This market includes a variety of drugs used to treat endocrine and metabolic disorders, such as diabetes, thyroid disorders, and obesity.
Some companies in the fludrocortisone market include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more